Literature DB >> 23165074

Lipids. Dalcetrapib raises HDL-cholesterol level, but does not reduce cardiac risk.

Gregory B Lim.   

Abstract

Entities:  

Year:  2012        PMID： 23165074     DOI： 10.1038/nrcardio.2012.171

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  1 in total

1.  Effects of dalcetrapib in patients with a recent acute coronary syndrome.

Authors:  Gregory G Schwartz; Anders G Olsson; Markus Abt; Christie M Ballantyne; Philip J Barter; Jochen Brumm; Bernard R Chaitman; Ingar M Holme; David Kallend; Lawrence A Leiter; Eran Leitersdorf; John J V McMurray; Hardi Mundl; Stephen J Nicholls; Prediman K Shah; Jean-Claude Tardif; R Scott Wright
Journal:  N Engl J Med       Date:  2012-11-05       Impact factor: 91.245
  1 in total
  1 in total

1.  High Density Lipoprotein Cholesterol Increasing Therapy: The Unmet Cardiovascular Need.

Authors:  Giovanni Cimmino; Giovanni Ciccarelli; Alberto Morello; Michele Ciccarelli; Paolo Golino
Journal:  Transl Med UniSa       Date:  2014-09-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.